[go: up one dir, main page]

NO992138D0 - FremgangsmÕter og sammensetninger for stimulering av neurittvekst - Google Patents

FremgangsmÕter og sammensetninger for stimulering av neurittvekst

Info

Publication number
NO992138D0
NO992138D0 NO992138A NO992138A NO992138D0 NO 992138 D0 NO992138 D0 NO 992138D0 NO 992138 A NO992138 A NO 992138A NO 992138 A NO992138 A NO 992138A NO 992138 D0 NO992138 D0 NO 992138D0
Authority
NO
Norway
Prior art keywords
compositions
methods
neurite outgrowth
stimulating neurite
stimulating
Prior art date
Application number
NO992138A
Other languages
English (en)
Other versions
NO328030B1 (no
NO992138L (no
Inventor
Robert E Zelle
Michael Su
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25009484&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO992138(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of NO992138D0 publication Critical patent/NO992138D0/no
Publication of NO992138L publication Critical patent/NO992138L/no
Publication of NO328030B1 publication Critical patent/NO328030B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Psychology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19992138A 1996-11-13 1999-05-03 Sammensetninger og anvendelse derav for fremstilling av medikamenter for stimulering av neurittvekst. NO328030B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/748,447 US5840736A (en) 1996-11-13 1996-11-13 Methods and compositions for stimulating neurite growth
PCT/US1997/020866 WO1998020891A1 (en) 1996-11-13 1997-11-13 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors

Publications (3)

Publication Number Publication Date
NO992138D0 true NO992138D0 (no) 1999-05-03
NO992138L NO992138L (no) 1999-07-13
NO328030B1 NO328030B1 (no) 2009-11-16

Family

ID=25009484

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992138A NO328030B1 (no) 1996-11-13 1999-05-03 Sammensetninger og anvendelse derav for fremstilling av medikamenter for stimulering av neurittvekst.

Country Status (33)

Country Link
US (3) US5840736A (no)
EP (1) EP0946190B1 (no)
JP (1) JP2001504470A (no)
KR (1) KR100544451B1 (no)
CN (1) CN1168442C (no)
AP (1) AP9901518A0 (no)
AR (1) AR011278A1 (no)
AT (1) ATE250424T1 (no)
AU (1) AU724833B2 (no)
BG (1) BG64670B1 (no)
BR (1) BR9712765A (no)
CA (1) CA2270634A1 (no)
CO (1) CO4930260A1 (no)
CZ (1) CZ296058B6 (no)
DE (1) DE69725169T2 (no)
DK (1) DK0946190T3 (no)
EA (1) EA004247B1 (no)
ES (1) ES2206753T3 (no)
HK (1) HK1022851A1 (no)
HU (1) HU226728B1 (no)
IL (1) IL129555A (no)
IN (1) IN183740B (no)
IS (1) IS2057B (no)
NO (1) NO328030B1 (no)
NZ (1) NZ335394A (no)
PL (1) PL190903B1 (no)
PT (1) PT946190E (no)
SK (1) SK284535B6 (no)
TR (1) TR199901034T2 (no)
TW (1) TW513302B (no)
UA (1) UA63926C2 (no)
WO (1) WO1998020891A1 (no)
ZA (1) ZA9710256B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US6242468B1 (en) 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
US6514686B2 (en) 1997-04-28 2003-02-04 The University Of British Columbia Method and composition for modulating amyloidosis
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US6852496B1 (en) 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
US5968921A (en) * 1997-10-24 1999-10-19 Orgegon Health Sciences University Compositions and methods for promoting nerve regeneration
KR20010052503A (ko) 1998-06-03 2001-06-25 다니엘 피. 맥컬럼 Ｎ-헤테로사이클릭 카복실산 또는 카복실산 등입체의ｎ-결합된 설폰아미드
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
KR20010071920A (ko) 1998-07-17 2001-07-31 개리 이. 프라이드만 뉴우런 성장 및 연장을 자극하는 화합물, 조성물 및 방법
GB9815880D0 (en) 1998-07-21 1998-09-16 Pfizer Ltd Heterocycles
US6395758B1 (en) 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US6218423B1 (en) 1998-08-14 2001-04-17 Gpi Nil Holdings, Inc. Pyrrolidine derivatives for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6228872B1 (en) 1998-11-12 2001-05-08 Bristol-Myers Squibb Company Neurotrophic diamide and carbamate agents
AU2173400A (en) * 1998-12-09 2000-06-26 Chiron Corporation Method for administering agents to the central nervous system
JP2002534414A (ja) * 1999-01-08 2002-10-15 バーテックス ファーマシューティカルズ インコーポレイテッド 医薬の製造に有用な中間体の形成方法
EP1196389A1 (en) * 1999-07-06 2002-04-17 Vertex Pharmaceuticals Incorporated N-heterocyclic derivatives with neuronal activity
US6734211B1 (en) 1999-07-09 2004-05-11 Oregon Health & Sciences University Compositions and methods for promoting nerve regeneration
MXPA02001095A (es) * 1999-07-30 2002-08-20 Vertex Pharma Derivados de amina ciclicos y aciclicos.
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
PT1227859E (pt) * 1999-11-12 2006-12-29 Alcon Inc Ligandos da neurofilina para o tratamento de patologias oculares
US6818643B1 (en) 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
US7060676B2 (en) 1999-12-20 2006-06-13 Trustees Of Tufts College T. cruzi-derived neurotrophic agents and methods of use therefor
WO2001046195A1 (en) 1999-12-21 2001-06-28 Gpi Nil Holdings, Inc. Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
US6555573B2 (en) 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
WO2002096356A2 (en) * 2001-05-25 2002-12-05 Cornell Research Foundation, Inc. HIGH AFFINITY LIGAND FOR p75 NEUROTROPHIN RECEPTOR
MXPA03011095A (es) * 2001-05-29 2005-04-28 Guilford Pharm Inc Metodo para tratar una lesion nerviosa causada por cirugia.
FR2825273B1 (fr) * 2001-05-29 2006-11-24 Oreal Composition pour le traitement des signes cutanes du vieillissement
US20030118536A1 (en) * 2001-11-06 2003-06-26 Rosenbloom Richard A. Topical compositions and methods for treatment of adverse effects of ionizing radiation
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
US7435725B2 (en) * 2001-11-06 2008-10-14 The Quigly Corporation Oral compositions and methods for prevention, reduction and treatment of radiation injury
US7232798B2 (en) 2001-11-13 2007-06-19 Tran Loi H Neuroprotection and neuroegenisis by administering cyclic prolyl glycine
US20100247483A1 (en) * 2001-11-13 2010-09-30 Tran Loi H Therapeutic agent composition and method of use
WO2003041655A2 (en) * 2001-11-13 2003-05-22 Loi Tran Therapeutic agent composition and method of use
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US8841326B2 (en) 2004-02-12 2014-09-23 Stc.Unm Therapeutic curcumin derivatives
CN101400367A (zh) * 2006-02-02 2009-04-01 瑞纳神经科学公司 施用trkb激动剂治疗不希望的重量减轻或进食障碍的方法
WO2007088479A1 (en) * 2006-02-02 2007-08-09 Rinat Neuroscience Corp. Methods for treating obesity by administering a trkb antagonist
KR20090091181A (ko) * 2006-12-20 2009-08-26 리나트 뉴로사이언스 코퍼레이션 자가면역 장애의 치료를 위한 티로신 수용체 키나아제 ｂ 작용제
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
AU2019271189A1 (en) 2018-05-15 2021-01-07 Lloyd Hung Loi TRAN Therapeutic agent composition and method of use, for treatment of mild cognitive impairment, depression, and psychological disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
IL115685A (en) * 1994-11-16 2000-08-31 Vertex Pharma Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
US5543423A (en) * 1994-11-16 1996-08-06 Vertex Pharmaceuticals, Incorporated Amino acid derivatives with improved multi-drug resistance activity
US5614547A (en) * 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5696135A (en) * 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US6037370A (en) * 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5811434A (en) * 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
JP5720848B2 (ja) * 2012-09-28 2015-05-20 Dic株式会社 多面体形状のα−アルミナ微粒子の製造方法

Also Published As

Publication number Publication date
ATE250424T1 (de) 2003-10-15
US5840736A (en) 1998-11-24
ES2206753T3 (es) 2004-05-16
TR199901034T2 (xx) 1999-07-21
PL190903B1 (pl) 2006-02-28
IL129555A0 (en) 2000-02-29
ZA9710256B (en) 1998-05-28
US6172086B1 (en) 2001-01-09
CN1168442C (zh) 2004-09-29
EP0946190A1 (en) 1999-10-06
IN183740B (no) 2000-04-01
KR100544451B1 (ko) 2006-01-24
IL129555A (en) 2005-08-31
BG64670B1 (bg) 2005-11-30
DE69725169T2 (de) 2004-07-15
SK62899A3 (en) 2000-04-10
EA199900464A1 (ru) 2000-02-28
PT946190E (pt) 2004-02-27
CO4930260A1 (es) 2000-06-27
AP9901518A0 (en) 1999-06-30
AR011278A1 (es) 2000-08-16
UA63926C2 (uk) 2004-02-16
EP0946190B1 (en) 2003-09-24
US6284778B1 (en) 2001-09-04
CA2270634A1 (en) 1998-05-22
IS5032A (is) 1999-04-21
HU226728B1 (en) 2009-08-28
HUP0001219A2 (hu) 2000-11-28
EA004247B1 (ru) 2004-02-26
AU724833B2 (en) 2000-09-28
KR20000068962A (ko) 2000-11-25
HK1022851A1 (en) 2000-08-25
DK0946190T3 (da) 2003-12-08
CZ296058B6 (cs) 2006-01-11
TW513302B (en) 2002-12-11
AU5258998A (en) 1998-06-03
BG103429A (en) 2000-04-28
NZ335394A (en) 2000-06-23
SK284535B6 (sk) 2005-06-02
WO1998020891A1 (en) 1998-05-22
PL333270A1 (en) 1999-11-22
CN1239433A (zh) 1999-12-22
JP2001504470A (ja) 2001-04-03
NO328030B1 (no) 2009-11-16
BR9712765A (pt) 1999-10-26
CZ168399A3 (cs) 1999-08-11
DE69725169D1 (de) 2003-10-30
IS2057B (is) 2005-10-14
HUP0001219A3 (en) 2001-12-28
NO992138L (no) 1999-07-13

Similar Documents

Publication Publication Date Title
NO992138D0 (no) FremgangsmÕter og sammensetninger for stimulering av neurittvekst
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
NO991676L (no) FremgangsmÕter og sammensetninger for immunmodulering
ZA9710248B (en) Methods and compositions for stimulating neurite growth.
ZA9710258B (en) Methods and compositions for stimulating neurite growth.
GR3036364T3 (en) Compositions and methods for treating or preventing inflammatory diseases
BR9609132A (pt) Composicão e método de tratamento de semente
ID16878A (id) Turunan indol yang bermanfaat untuk pengobatan
DK0926952T3 (da) Antimikrobiel sammensætning og fremgangsmåde til fremstilling deraf
NO985385D0 (no) Bitumensammensetninger og fremgangsmÕte for fremstilling derav
NO983435D0 (no) Aspartylproteaseinhibitorer
AU4248597A (en) Methods and compositions for treating preterm labor
NO984446D0 (no) FremgangsmÕte for behandling av smerte
DK0934375T3 (da) Polyolefinfibre og fremgangsmåde til fremstilling deraf
EP0781297A4 (en) CYTOTACTINE DERIVATIVES THAT STIMULATE NEURONAL CONNECTION AND GROWTH OF AXONES AND DENDRITES, THEIR PREPARATION AND USE METHODS
ID18300A (id) Metoda penemperan
NO983215D0 (no) Sammensetninger for behandling av hudpÕvirkninger og fremgangsmaate for dens fremstilling
ID16924A (id) Metode perlakuan poliolefin
PL328795A1 (en) Method of obtaining n-rotected derivatives of d-proline
SI0946190T1 (en) Methods and compositions for stimulating neurite outgrowth
DK0863948T3 (da) Bitumenkompositioner og fremgangsmåde til fremstilling deraf
NO952766L (no) Opplösningsmiddelsammensetninger og metoder
NO984525L (no) Butadienderivater og fremgangsmÕte for fremstilling derav
ATA68297A (de) Pasteurisiervorrichtung
DK1042286T3 (da) Gamme-glutamyl- og beta-aspartyl-holdige immunmodulerende forbindelser og tilhørense fremgangsmåder

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees